SCHEMBL25517166

SCHEMBL25517166

Cc1ccc2c(c1)sc1cc(-c3cc(C)c(C)c(C)c3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
RAB9A P51151 7/20 0.38
NPC1 O15118 6/20 0.38
MAPT P10636 7/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
APP P05067 7/20 0.36
SNCA P37840 3/20 0.36
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ESR1 P03372 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25517177 0.92 IDO1 (0.33) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL10133862 0.89 BCL2L1 (0.44) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL15599403 0.85 MCL1 (0.42) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL15599413 0.81 MCL1 (0.40) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL14680638 0.81 ESR1 (0.41) BCL2L1MCL1RAB9AMAPTLMNA
SCHEMBL812518 0.80 BCL2L1 (0.50) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL14295769 0.80 LIMK1 (0.44) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL20156869 0.80 MAPT (0.41) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL10133864 0.79 BCL2L1 (0.38) BCL2L1MCL1RAB9ANPC1MAPT
SCHEMBL10133866 0.79 BCL2L1 (0.41) BCL2L1MCL1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320191-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-10-05 US disclosed
US-11659763-B2 Metal complexes MERCK PATENT GMBH 2023-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320191-A1 METAL COMPLEXES IMMT, MCU, SOD1 BCL2L1 2366/4885MCL1 2794/4885RAB9A 2000/4885
US-11659763-B2 Metal complexes IMMT, MCU, SOD1 BCL2L1 2366/4885MCL1 2794/4885RAB9A 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.